The antipsychotic Trifluoperazine (cas 117-89-5) reduces marble-burying behavior in mice via D2 and 5-HT2A receptors: Implications for obsessive–compulsive disorder
-
Add time:08/29/2019 Source:sciencedirect.com
Trifluoperazine (cas 117-89-5), a typical antipsychotic drug, not only antagonizes dopamine D2 receptors but also enhances serotonin 5-HT2 receptor-mediated behavior. Moreover, trifluoperazine suppresses human purinergic receptor P2X7 responses and calmodulin. However, the effect of trifluoperazine on marble-burying behavior, which has been considered an animal model of obsessive–compulsive disorder (OCD), has not been studied. Here, we examined the effect of trifluoperazine on marble-burying behavior in mice. Oral administration of paroxetine, a selective serotonin reuptake inhibitor, significantly reduced marble-burying behavior without affecting total locomotor activity. Similar results were obtained for trifluoperazine (3 mg/kg). The D2 receptor agonist, quinpirole (0.03 mg/kg, intraperitoneal [i.p.]), and 5-HT2A receptor antagonist, ketanserin (0.3 mg/kg, i.p.), significantly counteracted this reduction of marble-burying behavior by trifluoperazine. These results show that trifluoperazine reduces marble-burying behavior via D2 and 5-HT2A receptors, and may be a useful drug for the treatment of OCD.
We also recommend Trading Suppliers and Manufacturers of Trifluoperazine (cas 117-89-5). Pls Click Website Link as below: cas 117-89-5 suppliers
Prev:A chemical screen identifies Trifluoperazine (cas 117-89-5) as an inhibitor of glioblastoma growth
Next:Block of Kv4.3 potassium channel by Trifluoperazine (cas 117-89-5) independent of CaMKII) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- The calmodulin inhibitor and antipsychotic drug Trifluoperazine (cas 117-89-5) inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells09/03/2019
- ORIGINAL ARTICLESeparation and determination of Trifluoperazine (cas 117-89-5) and prochlorperazine in pharmaceutical preparations by HPLC09/02/2019
- Original articleMean centering of ratio spectra and successive derivative ratio spectrophotometric methods for determination of isopropamide iodide, Trifluoperazine (cas 117-89-5) hydrochloride and Trifluoperazine (cas 117-89-5) oxidative degradate09/01/2019
- Trifluoperazine (cas 117-89-5) blocks the human cardiac sodium channel, Nav1.5, independent of calmodulin08/31/2019
- Block of Kv4.3 potassium channel by Trifluoperazine (cas 117-89-5) independent of CaMKII08/30/2019
- A chemical screen identifies Trifluoperazine (cas 117-89-5) as an inhibitor of glioblastoma growth08/28/2019
- Reprint of: A chemical screen identifies Trifluoperazine (cas 117-89-5) as an inhibitor of glioblastoma growth08/27/2019
- Research paperRepositioning of the antipsychotic Trifluoperazine (cas 117-89-5): Synthesis, biological evaluation and in silico study of Trifluoperazine (cas 117-89-5) analogs as anti-glioblastoma agents08/26/2019
-
Health and Chemical more >